Viewing Study NCT04164459


Ignite Creation Date: 2025-12-24 @ 3:06 PM
Ignite Modification Date: 2026-01-19 @ 3:46 PM
Study NCT ID: NCT04164459
Status: UNKNOWN
Last Update Posted: 2019-11-15
First Post: 2019-10-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluating the Efficacy and Safety of Xalost S in Glaucoma Patients.
Sponsor: Taejoon Pharmaceutical Co., Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: TJO-002-401
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators